These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 18940282)
21. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial. Daemen J; Kuck KH; Macaya C; LeGrand V; Vrolix M; Carrie D; Sheiban I; Suttorp MJ; Vranckx P; Rademaker T; Goedhart D; Schuijer M; Wittebols K; Macours N; Stoll HP; Serruys PW; J Am Coll Cardiol; 2008 Dec; 52(24):1957-67. PubMed ID: 19055986 [TBL] [Abstract][Full Text] [Related]
22. Efficacy of oral nicorandil in patients with end-stage renal disease: a retrospective chart review after coronary angioplasty in Japanese patients receiving hemodialysis. Ishii H; Toriyama T; Aoyama T; Takahashi H; Yamada S; Kasuga H; Ichimiya S; Kanashiro M; Mitsuhashi H; Maruyama S; Matsuo S; Naruse K; Matsubara T; Murohara T Clin Ther; 2007 Jan; 29(1):110-22. PubMed ID: 17379051 [TBL] [Abstract][Full Text] [Related]
23. Usefulness of serum high-density lipoprotein cholesterol level as an independent predictor of one-year mortality after percutaneous coronary interventions. Ghazzal ZB; Dhawan SS; Sheikh A; Douglas JS; Veledar E; Mavromatis K; Pohlel FK; Vaccarino V Am J Cardiol; 2009 Apr; 103(7):902-6. PubMed ID: 19327413 [TBL] [Abstract][Full Text] [Related]
24. Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris. Gach O; Legrand V; Biessaux Y; Chapelle JP; Vanbelle S; Pierard LA Am J Cardiol; 2007 Jan; 99(1):31-5. PubMed ID: 17196457 [TBL] [Abstract][Full Text] [Related]
25. Chronic obstructive pulmonary disease as a predictor of mortality in patients undergoing percutaneous coronary intervention. Selvaraj CL; Gurm HS; Gupta R; Ellis SG; Bhatt DL Am J Cardiol; 2005 Sep; 96(6):756-9. PubMed ID: 16169353 [TBL] [Abstract][Full Text] [Related]
26. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial. Ishani A; Grandits GA; Grimm RH; Svendsen KH; Collins AJ; Prineas RJ; Neaton JD J Am Soc Nephrol; 2006 May; 17(5):1444-52. PubMed ID: 16611715 [TBL] [Abstract][Full Text] [Related]
27. Comparison of effectiveness of atorvastatin 10 mg versus 80 mg in reducing major cardiovascular events and repeat revascularization in patients with previous percutaneous coronary intervention (post hoc analysis of the Treating to New Targets [TNT] Study). Johnson C; Waters DD; DeMicco DA; Breazna A; Bittner V; Greten H; Grundy SM; LaRosa JC Am J Cardiol; 2008 Nov; 102(10):1312-7. PubMed ID: 18993147 [TBL] [Abstract][Full Text] [Related]
28. Analysis of recurrent revascularization events following percutaneous coronary intervention of diabetic patients. Anselmino M; Delcrè S; Moretti C; Biondi-Zoccai G; Omedè P; Sciuto F; Trevi GP; Sheiban I Minerva Cardioangiol; 2009 Apr; 57(2):151-7. PubMed ID: 19274025 [TBL] [Abstract][Full Text] [Related]
29. Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial). Boden WE; O'Rourke RA; Teo KK; Maron DJ; Hartigan PM; Sedlis SP; Dada M; Labedi M; Spertus JA; Kostuk WJ; Berman DS; Shaw LJ; Chaitman BR; Mancini GB; Weintraub WS; Am J Cardiol; 2009 Jul; 104(1):1-4. PubMed ID: 19576311 [TBL] [Abstract][Full Text] [Related]
30. Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) Registries. Yan BP; Clark DJ; Buxton B; Ajani AE; Smith JA; Duffy SJ; Shardey GC; Skillington PD; Farouque O; Yii M; Yap CH; Andrianopoulos N; Brennan A; Dinh D; Reid CM; ; Heart Lung Circ; 2009 Jun; 18(3):184-90. PubMed ID: 19268632 [TBL] [Abstract][Full Text] [Related]
31. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up. Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF Circulation; 2009 Jan; 119(2):237-42. PubMed ID: 19118249 [TBL] [Abstract][Full Text] [Related]
33. Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease. Shechter M; Issachar A; Marai I; Koren-Morag N; Freinark D; Shahar Y; Shechter A; Feinberg MS Int J Cardiol; 2009 May; 134(1):52-8. PubMed ID: 18479768 [TBL] [Abstract][Full Text] [Related]
34. Preoperative cardiac risk index predicts long-term mortality and health status. Hoeks SE; op Reimer WJ; van Gestel YR; Smolderen KG; Verhagen H; van Domburg RT; van Urk H; Poldermans D Am J Med; 2009 Jun; 122(6):559-65. PubMed ID: 19376487 [TBL] [Abstract][Full Text] [Related]
35. A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system. Harjai KJ; Raizada A; Shenoy C; Sattur S; Orshaw P; Yaeger K; Boura J; Aboufares A; Sporn D; Stapleton D Am J Cardiol; 2008 Mar; 101(6):812-9. PubMed ID: 18328846 [TBL] [Abstract][Full Text] [Related]
36. Comparison of the impact of short (<1 year) and long-term (> or =1 year) clopidogrel use following percutaneous coronary intervention on mortality. Banerjee S; Varghese C; Samuel J; Weideman RA; Little BB; Kelly KC; Rao SV; Reilly RF; Brilakis ES Am J Cardiol; 2008 Nov; 102(9):1159-62. PubMed ID: 18940284 [TBL] [Abstract][Full Text] [Related]